AL-15469A for the Treatment of Bacterial Conjunctivitis

Status

Completed

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00331916

Enrollment

600

Registered

2006-05-31

Start date

2005-11-30

Completion date

Unknown

Last updated

2009-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bacterial Conjunctivitis

Brief summary

The purpose of the study is to determine whether AL-15469A is safe and effective in the treatment of bacterial conjunctivitis.

Interventions

DRUGquinolone

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE

Eligibility

Sex/Gender

ALL

Age

1 Months to No maximum

Healthy volunteers

Inclusion criteria

* Signs & Symptoms of conjunctivitis

Exclusion criteria

* Under 1 mo. age

Design outcomes

Primary

Measure	Time frame
Clinical cure and microbiological success	—

Secondary

Measure	Time frame
Individual signs and symptoms of bacterial conjunctivitis at each visit	—

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026